CI,,,if memory serves me, I think The lack of news or agreement coming out of Mexico was because they wanted to use LL in a combination therapy and Nader flatly said it was to be used as a monotherapy.
I think he wanted to avoid tainting the evidence or didn't want anyone to think that LL needed to be combined to be efficacious.
The Big boys of Pharma may be looking to their own collaborative Pharm teams, before they would agree to a hookup with a microBio. I agree...you have to wonder what the hell, they are waiting for, given our MOA.